Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 12, Issue 7
Merkel cell carcinoma refractory to anti-PD(L)1: utility of adding ipilimumab for salvage therapy
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Commentary
Merkel cell carcinoma refractory to anti-PD(L)1: utility of adding ipilimumab for salvage therapy
Online download statistics by month:
Online download statistics by month: July 2024 to September 2025
Abstract
Full
Pdf
Jul 2024
225
226
46
Aug 2024
197
197
84
Sep 2024
86
87
46
Oct 2024
77
78
48
Nov 2024
69
70
31
Dec 2024
84
85
31
Jan 2025
67
69
36
Feb 2025
164
164
32
Mar 2025
61
62
27
Apr 2025
76
76
30
May 2025
48
48
29
Jun 2025
59
59
36
Jul 2025
1
1
0
Aug 2025
1
1
0
Sep 2025
5
5
0
Total
1220
1228
476
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF